{"id":"NCT00226499","sponsor":"GlaxoSmithKline","briefTitle":"Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox","officialTitle":"Study in Healthy Children (<2 Years) to Evaluate the Safety and Efficacy of GSK Biologicals' Live Attenuated Varicella Vaccine (VarilrixTM) and of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-09-01","primaryCompletion":"2006-10-12","completion":"2006-10-12","firstPosted":"2005-09-27","resultsPosted":"2019-09-23","lastUpdate":"2019-09-23"},"enrollment":5803,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Varicella","Chickenpox Vaccines"],"interventions":[{"type":"BIOLOGICAL","name":"Priorix-tetra™","otherNames":[]},{"type":"BIOLOGICAL","name":"Priorix™","otherNames":[]},{"type":"BIOLOGICAL","name":"Varilrix™","otherNames":[]}],"arms":[{"label":"MMRV Group","type":"EXPERIMENTAL"},{"label":"OKAH Group","type":"EXPERIMENTAL"},{"label":"MMR Group","type":"ACTIVE_COMPARATOR"}],"summary":"An observer-blind study to evaluate GlaxoSmithKline Biologicals' live attenuated varicella vaccine and GlaxoSmithKline Biologicals' combined measles-mumps-rubella-varicella vaccine in the prevention of varicella disease in children. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.","primaryOutcome":{"measure":"Phase A: Number of Subjects With Confirmed Varicella Case","timeFrame":"From 42 days post dose 2 until the end of Phase A","effectByArm":[{"arm":"MMRV Group","deltaMin":37,"sd":null},{"arm":"OKAH Group","deltaMin":243,"sd":null},{"arm":"MMR Group","deltaMin":201,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"0.1265"}]},"eligibility":{"minAge":"11 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":12},"locations":{"siteCount":104,"countries":["Czechia","Greece","Italy","Lithuania","Norway","Poland","Romania","Russia","Slovakia","Sweden"]},"refs":{"pmids":["29224964","24485548","31345639","33736915","30765242"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":649,"n":2489},"commonTop":["Pyrexia","Injection site erythema","Injection site pain"]}}